134 related articles for article (PubMed ID: 10449179)
1. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells.
Rovere P; Sabbadini MG; Vallinoto C; Fascio U; Zimmermann VS; Bondanza A; Ricciardi-Castagnoli P; Manfredi AA
J Leukoc Biol; 1999 Aug; 66(2):345-9. PubMed ID: 10449179
[TBL] [Abstract][Full Text] [Related]
2. Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.
Albert ML; Pearce SF; Francisco LM; Sauter B; Roy P; Silverstein RL; Bhardwaj N
J Exp Med; 1998 Oct; 188(7):1359-68. PubMed ID: 9763615
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell presentation of antigens from apoptotic cells in a proinflammatory context: role of opsonizing anti-beta2-glycoprotein I antibodies.
Rovere P; Sabbadini MG; Vallinoto C; Fascio U; Recigno M; Crosti M; Ricciardi-Castagnoli P; Balestrieri G; Tincani A; Manfredi AA
Arthritis Rheum; 1999 Jul; 42(7):1412-20. PubMed ID: 10403269
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and participating in the development of anti-inflammatory functional behavior of phagocytic macrophages.
Filaci G; Contini P; Fravega M; Fenoglio D; Azzarone B; Julien-Giron M; Fiocca R; Boggio M; Necchi V; De Lerma Barbaro A; Merlo A; Rizzi M; Ghio M; Setti M; Puppo F; Zanetti M; Indiveri F
Hum Immunol; 2003 Jan; 64(1):9-20. PubMed ID: 12507810
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
Adams EW; Ratner DM; Seeberger PH; Hacohen N
Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
[TBL] [Abstract][Full Text] [Related]
8. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function.
Rovere P; Vallinoto C; Bondanza A; Crosti MC; Rescigno M; Ricciardi-Castagnoli P; Rugarli C; Manfredi AA
J Immunol; 1998 Nov; 161(9):4467-71. PubMed ID: 9794367
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen.
Labarrière N; Bretaudeau L; Gervois N; Bodinier M; Bougras G; Diez E; Lang F; Gregoire M; Jotereau F
Int J Cancer; 2002 Sep; 101(3):280-6. PubMed ID: 12209980
[TBL] [Abstract][Full Text] [Related]
10. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
[TBL] [Abstract][Full Text] [Related]
11. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
13. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies.
Steinman RM; Inaba K; Turley S; Pierre P; Mellman I
Hum Immunol; 1999 Jul; 60(7):562-7. PubMed ID: 10426272
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.
Huang J; Tatsumi T; Pizzoferrato E; Vujanovic N; Storkus WJ
Cancer Res; 2005 Sep; 65(18):8461-70. PubMed ID: 16166326
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation.
Blachère NE; Darnell RB; Albert ML
PLoS Biol; 2005 Jun; 3(6):e185. PubMed ID: 15839733
[TBL] [Abstract][Full Text] [Related]
16. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
Mitchell DA; Nair SK; Gilboa E
Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
[TBL] [Abstract][Full Text] [Related]
18. Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
von Euw EM; Barrio MM; Furman D; Bianchini M; Levy EM; Yee C; Li Y; Wainstok R; Mordoh J
J Transl Med; 2007 Apr; 5():19. PubMed ID: 17448240
[TBL] [Abstract][Full Text] [Related]
19. The consequences of apoptosis in autoimmunity.
Lleo A; Selmi C; Invernizzi P; Podda M; Gershwin ME
J Autoimmun; 2008 Nov; 31(3):257-62. PubMed ID: 18513925
[TBL] [Abstract][Full Text] [Related]
20. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.
Sauter B; Albert ML; Francisco L; Larsson M; Somersan S; Bhardwaj N
J Exp Med; 2000 Feb; 191(3):423-34. PubMed ID: 10662788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
